Menzies-Gow, Andrew
Ponnarambil, Sandhia
Downie, John
Bowen, Karin
Hellqvist, Åsa
Colice, Gene
Funding for this research was provided by:
AstraZeneca
Amgen, Inc
Article History
Received: 2 July 2020
Accepted: 11 October 2020
First Online: 21 October 2020
Ethical approval and consent to participate
: Written informed consent will be obtained from all patients or their guardians before enrolment into the study and before entry into the extended follow-up period for eligible patients. The study will be conducted in accordance with the principles established in the Declaration of Helsinki and the International Council for Harmonisation guidelines for good clinical practice.
: Not applicable.
: AMG has attended advisory boards for AstraZeneca, GlaxoSmithKline, Novartis, Sanofi and Teva. He has received speaker fees from AstraZeneca, Novartis, Roche and Teva. He has participated in research with AstraZeneca for which his institution has been remunerated and has attended international conferences with Teva. He has had consultancy agreements with AstraZeneca, Sanofi and Vectura. GC, SP, KB and ÅH are employees of AstraZeneca. JD is an employee of Amgen Inc.